The treatment of multidrug-resistant Pseudomonas aeruginosa with polymyxin B or E in a patient with the highly pathogenic avian influenza A (H 5N 1) infection: A case report and review of the literature

Chinese Journal of Antibiotics

Volumn 32, Issue 11, 2007, Pages 685-688

  Zhou, Bo Ping ^a   Lu, Jian ^a   Qiu, Chen ^a   Wu, Shi Pin ^a   Song, Wei Dong ^b   Yang, Da Guo ^a   Fu, Ying Yun ^a   Gao, Xue ^c   Liu, Xue Yan ^a   Liu, Shui Teng ^a   Lu, Pu Xuan ^a   Shan, Wan Shui ^a   Li, Yi Min ^d   Yuan, Guo Yong ^e   Zhong, Nan Shan ^d  

^a China   (China)

^b PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^c Shenzhen Municipal Traditional Chinese Medicine Hospital   (China)

^d GUANGZHOU MEDICAL UNIVERSITY   (China)

^e Hongkong University Microbiology Department

Author keywords

Avian influenza A virus; Polymyxin; Pseudomonas aeruginosa

Indexed keywords

COLISTIN; POLYMYXIN B;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; AVIAN INFLUENZA; CASE REPORT; GRAM NEGATIVE INFECTION; HUMAN; INFLUENZA VIRUS A H5N1; LUNG INFECTION; MALE; MULTIDRUG RESISTANCE; PSEUDOMONAS AERUGINOSA; SPUTUM CULTURE; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 37049013283     PISSN: 10018689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Wong S S, Yuen K Y. Avian influenza virus infections in humans [j]. Chest, 2006, 129(1):156-168.
2. 1) in 10 patients in Vietnam [J]. N Engl J Med, 2004, 350(12):1179-1188.
3. 1) infection in humans [J]. N Engl J Med, 2005, 353(13):1374-1385.
4. Chinese source
5. Chinese source
6. Park D R. Antimicrobial treatment of ventilator-associated pneumonia [J]. Respir Care, 2005, 50(7):932-952.
7. Reina R, Estenssoro E, Saenz G, et al. Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study [J]. Intensive Care Med, 2005, 31(8):1058-1065.
8. Falagas M E, Kasiakou S K, Tsiodras S, et al. The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature [J]. Clin Med Res, 2006, 4(2):138-146.
9. Sobieszczyk M E, Furuya E Y, Hay C M, et al. Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections [J]. J Antimicrob Chemother, 2004, 54(2):566-569.
10. Kollef M H. Microbiological diagnosis of ventilator-associated pneumonia: using the data to optimize clinical outcomes [J]. Am J Respir Crit Care Med, 2006, 173(11):1182-1184.